Endo International PLC - ESG Rating & Company Profile powered by AI
The report of Endo International PLC was prepared by All Street Sevva using leading Cognitive Robots. This Disclosure rating includes seventeen UN SDGs including: 'Gender Equality', 'Responsible Production & Consumption' and 'Life on Land'. This page contains a free ESG assessment covering Endo International PLC.
Endo International PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Endo International PLC | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Endo International PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Endo International PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Endo International PLC report the average age of the workforce?
Sign up for free to unlockDoes Endo International PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Endo International PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Endo International PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Endo International PLC offer flexible work?
Sign up for free to unlockDoes Endo International PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Endo International PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Endo International PLC conduct supply chain audits?
Sign up for free to unlockDoes Endo International PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Endo International PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Endo International PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Endo International PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Endo International PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Endo International PLC disclose water use targets?
Sign up for free to unlockDoes Endo International PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Endo International PLC have a product recall in the last two years?
Sign up for free to unlockDoes Endo International PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Endo International PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Endo International PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Endo International PLC disclose parental leave metrics?
Sign up for free to unlockDoes Endo International PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Endo International PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Endo International PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Endo International PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Endo International PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Endo International PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Endo International PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Endo International PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Endo International PLC disclose its waste policy?
Sign up for free to unlockDoes Endo International PLC report according to TCFD requirements?
Sign up for free to unlockDoes Endo International PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Endo International PLC disclose energy use targets?
Sign up for free to unlockDoes Endo International PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Endo International PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Endo International PLC
These potential risks are based on the size, segment and geographies of the company.
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court